Design and baseline data from the vanguard of the Comparison of Depression Interventions after Acute Coronary Syndrome (CODIACS) randomized controlled trial

Abstract This paper describes the rationale and design of the vanguard for the Comparison of Depression Interventions after Acute Coronary Syndrome (CODIACS), a multicenter, randomized, controlled trial of a patient preference‐based, stepped care protocol for persistent depressive symptoms after acu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Contemporary clinical trials 2012-09, Vol.33 (5), p.1003-1010
Hauptverfasser: Whang, William, Burg, Matthew M, Carney, Robert M, Freedland, Kenneth E, Bigger, J. Thomas, Catellier, Diane, Czajkowski, Susan, Frasure-Smith, Nancy, Haas, Donald C, Jaffe, Allan S, Lespérance, Francois, Medina, Vivian, Duer-Hefele, Joan, Osorio, Gabrielle A, Parsons, Faith, Shapiro, Peter A, Sheps, David S, Vaccarino, Viola, Davidson, Karina W
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1010
container_issue 5
container_start_page 1003
container_title Contemporary clinical trials
container_volume 33
creator Whang, William
Burg, Matthew M
Carney, Robert M
Freedland, Kenneth E
Bigger, J. Thomas
Catellier, Diane
Czajkowski, Susan
Frasure-Smith, Nancy
Haas, Donald C
Jaffe, Allan S
Lespérance, Francois
Medina, Vivian
Duer-Hefele, Joan
Osorio, Gabrielle A
Parsons, Faith
Shapiro, Peter A
Sheps, David S
Vaccarino, Viola
Davidson, Karina W
description Abstract This paper describes the rationale and design of the vanguard for the Comparison of Depression Interventions after Acute Coronary Syndrome (CODIACS), a multicenter, randomized, controlled trial of a patient preference‐based, stepped care protocol for persistent depressive symptoms after acute coronary syndrome (ACS). The overall aim of the vanguard phase was to determine whether the patient-preference, stepped care protocol, which is based on the intervention used in the recent Coronary Psychosocial Evaluation Studies (COPES) trial, was feasible in patients with recent ACS who were recruited from 5 geographically diverse sites. Innovative design features of this trial include randomization to either initial patient-preference of treatment or to a referred care arm in which the primary care provider decided upon care. Additionally, delivery of psychotherapy was accomplished by telephone, or webcam, depending upon patient preference. The vanguard phase provides estimates of eligibility and screening/enrollment ratios, patient acceptance of screening, and retention. In this report, we describe the innovative features and the baseline results of the vanguard phase of CODIACS. The data from this vanguard study will be used to finalize planning for a large, phase III clinical trial designed to evaluate the effect of treatment on depressive symptoms, coronary events, and death.
doi_str_mv 10.1016/j.cct.2012.05.005
format Article
fullrecord <record><control><sourceid>elsevier_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3408827</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1551714412001322</els_id><sourcerecordid>S1551714412001322</sourcerecordid><originalsourceid>FETCH-LOGICAL-c506t-7190f85deaffd27ff984b0f9feef40a946cbee8cbe22e5c07b176ede2094f1f03</originalsourceid><addsrcrecordid>eNp9Uk2P0zAQjRCIXRZ-ABfkI3toGDtxPoS0UpXyUWmlPRTOlmOPuy6JXdlppfJb-LE4W1gBBy72PHveG4_fZNlrCjkFWr3b5UpNOQPKcuA5AH-SXVLO2wWDAp4-xHRR07K8yF7EuAMoKl7x59kFY1UJLSsvsx8rjHbriHSa9DLiYB0SLSdJTPAjme6RHKXbHmTQxJsH3PlxL4ON3s0nK9wHjNEmtHYThiO6KYFIpEmILNVhminBOxlOZHNyOukiedvdrdbLbnNNQirtR_sdNVHeTcEPQwqnYOXwMntm5BDx1a_9Kvv68cOX7vPi9u7TulveLhSHakodtmAarlEao1ltTNuUPZjWIJoSZFtWqkds0sIYcgV1T-sKNTJoS0MNFFfZzVl3f-hH1Cq1EOQg9sGO6dHCSyv-vnH2Xmz9URQlNA2rkwA9C6jgYwxoHrkUxGyV2IlklZitEsBFsipx3vxZ9JHx25uU8P6cgKn1o8UgorLoFGobMIlpb_8rf_MPWyVvrZLDNzxh3PlDcOlPBRUxccRmnpV5VCgDoAVjxU-Dhr5e</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Design and baseline data from the vanguard of the Comparison of Depression Interventions after Acute Coronary Syndrome (CODIACS) randomized controlled trial</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Whang, William ; Burg, Matthew M ; Carney, Robert M ; Freedland, Kenneth E ; Bigger, J. Thomas ; Catellier, Diane ; Czajkowski, Susan ; Frasure-Smith, Nancy ; Haas, Donald C ; Jaffe, Allan S ; Lespérance, Francois ; Medina, Vivian ; Duer-Hefele, Joan ; Osorio, Gabrielle A ; Parsons, Faith ; Shapiro, Peter A ; Sheps, David S ; Vaccarino, Viola ; Davidson, Karina W</creator><creatorcontrib>Whang, William ; Burg, Matthew M ; Carney, Robert M ; Freedland, Kenneth E ; Bigger, J. Thomas ; Catellier, Diane ; Czajkowski, Susan ; Frasure-Smith, Nancy ; Haas, Donald C ; Jaffe, Allan S ; Lespérance, Francois ; Medina, Vivian ; Duer-Hefele, Joan ; Osorio, Gabrielle A ; Parsons, Faith ; Shapiro, Peter A ; Sheps, David S ; Vaccarino, Viola ; Davidson, Karina W</creatorcontrib><description>Abstract This paper describes the rationale and design of the vanguard for the Comparison of Depression Interventions after Acute Coronary Syndrome (CODIACS), a multicenter, randomized, controlled trial of a patient preference‐based, stepped care protocol for persistent depressive symptoms after acute coronary syndrome (ACS). The overall aim of the vanguard phase was to determine whether the patient-preference, stepped care protocol, which is based on the intervention used in the recent Coronary Psychosocial Evaluation Studies (COPES) trial, was feasible in patients with recent ACS who were recruited from 5 geographically diverse sites. Innovative design features of this trial include randomization to either initial patient-preference of treatment or to a referred care arm in which the primary care provider decided upon care. Additionally, delivery of psychotherapy was accomplished by telephone, or webcam, depending upon patient preference. The vanguard phase provides estimates of eligibility and screening/enrollment ratios, patient acceptance of screening, and retention. In this report, we describe the innovative features and the baseline results of the vanguard phase of CODIACS. The data from this vanguard study will be used to finalize planning for a large, phase III clinical trial designed to evaluate the effect of treatment on depressive symptoms, coronary events, and death.</description><identifier>ISSN: 1551-7144</identifier><identifier>EISSN: 1559-2030</identifier><identifier>DOI: 10.1016/j.cct.2012.05.005</identifier><identifier>PMID: 22640924</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Acute coronary syndrome ; Acute Coronary Syndrome - psychology ; Aged ; Cardiovascular ; Clinical Protocols ; Clinical trial ; Depression ; Depression - complications ; Depression - therapy ; Female ; Hematology, Oncology and Palliative Medicine ; Humans ; Male ; Middle Aged ; Myocardial Infarction - etiology ; Patient Preference ; Patient Selection ; Psychotherapy - methods ; Secondary Prevention ; Serotonin Uptake Inhibitors - administration &amp; dosage ; Serotonin Uptake Inhibitors - adverse effects ; Serotonin Uptake Inhibitors - therapeutic use ; Socioeconomic Factors</subject><ispartof>Contemporary clinical trials, 2012-09, Vol.33 (5), p.1003-1010</ispartof><rights>Elsevier Inc.</rights><rights>2012 Elsevier Inc.</rights><rights>Copyright © 2012 Elsevier Inc. All rights reserved.</rights><rights>2012 Elsevier Inc. All rights reserved. 2012</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c506t-7190f85deaffd27ff984b0f9feef40a946cbee8cbe22e5c07b176ede2094f1f03</citedby><cites>FETCH-LOGICAL-c506t-7190f85deaffd27ff984b0f9feef40a946cbee8cbe22e5c07b176ede2094f1f03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1551714412001322$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,776,780,881,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22640924$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Whang, William</creatorcontrib><creatorcontrib>Burg, Matthew M</creatorcontrib><creatorcontrib>Carney, Robert M</creatorcontrib><creatorcontrib>Freedland, Kenneth E</creatorcontrib><creatorcontrib>Bigger, J. Thomas</creatorcontrib><creatorcontrib>Catellier, Diane</creatorcontrib><creatorcontrib>Czajkowski, Susan</creatorcontrib><creatorcontrib>Frasure-Smith, Nancy</creatorcontrib><creatorcontrib>Haas, Donald C</creatorcontrib><creatorcontrib>Jaffe, Allan S</creatorcontrib><creatorcontrib>Lespérance, Francois</creatorcontrib><creatorcontrib>Medina, Vivian</creatorcontrib><creatorcontrib>Duer-Hefele, Joan</creatorcontrib><creatorcontrib>Osorio, Gabrielle A</creatorcontrib><creatorcontrib>Parsons, Faith</creatorcontrib><creatorcontrib>Shapiro, Peter A</creatorcontrib><creatorcontrib>Sheps, David S</creatorcontrib><creatorcontrib>Vaccarino, Viola</creatorcontrib><creatorcontrib>Davidson, Karina W</creatorcontrib><title>Design and baseline data from the vanguard of the Comparison of Depression Interventions after Acute Coronary Syndrome (CODIACS) randomized controlled trial</title><title>Contemporary clinical trials</title><addtitle>Contemp Clin Trials</addtitle><description>Abstract This paper describes the rationale and design of the vanguard for the Comparison of Depression Interventions after Acute Coronary Syndrome (CODIACS), a multicenter, randomized, controlled trial of a patient preference‐based, stepped care protocol for persistent depressive symptoms after acute coronary syndrome (ACS). The overall aim of the vanguard phase was to determine whether the patient-preference, stepped care protocol, which is based on the intervention used in the recent Coronary Psychosocial Evaluation Studies (COPES) trial, was feasible in patients with recent ACS who were recruited from 5 geographically diverse sites. Innovative design features of this trial include randomization to either initial patient-preference of treatment or to a referred care arm in which the primary care provider decided upon care. Additionally, delivery of psychotherapy was accomplished by telephone, or webcam, depending upon patient preference. The vanguard phase provides estimates of eligibility and screening/enrollment ratios, patient acceptance of screening, and retention. In this report, we describe the innovative features and the baseline results of the vanguard phase of CODIACS. The data from this vanguard study will be used to finalize planning for a large, phase III clinical trial designed to evaluate the effect of treatment on depressive symptoms, coronary events, and death.</description><subject>Acute coronary syndrome</subject><subject>Acute Coronary Syndrome - psychology</subject><subject>Aged</subject><subject>Cardiovascular</subject><subject>Clinical Protocols</subject><subject>Clinical trial</subject><subject>Depression</subject><subject>Depression - complications</subject><subject>Depression - therapy</subject><subject>Female</subject><subject>Hematology, Oncology and Palliative Medicine</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Myocardial Infarction - etiology</subject><subject>Patient Preference</subject><subject>Patient Selection</subject><subject>Psychotherapy - methods</subject><subject>Secondary Prevention</subject><subject>Serotonin Uptake Inhibitors - administration &amp; dosage</subject><subject>Serotonin Uptake Inhibitors - adverse effects</subject><subject>Serotonin Uptake Inhibitors - therapeutic use</subject><subject>Socioeconomic Factors</subject><issn>1551-7144</issn><issn>1559-2030</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9Uk2P0zAQjRCIXRZ-ABfkI3toGDtxPoS0UpXyUWmlPRTOlmOPuy6JXdlppfJb-LE4W1gBBy72PHveG4_fZNlrCjkFWr3b5UpNOQPKcuA5AH-SXVLO2wWDAp4-xHRR07K8yF7EuAMoKl7x59kFY1UJLSsvsx8rjHbriHSa9DLiYB0SLSdJTPAjme6RHKXbHmTQxJsH3PlxL4ON3s0nK9wHjNEmtHYThiO6KYFIpEmILNVhminBOxlOZHNyOukiedvdrdbLbnNNQirtR_sdNVHeTcEPQwqnYOXwMntm5BDx1a_9Kvv68cOX7vPi9u7TulveLhSHakodtmAarlEao1ltTNuUPZjWIJoSZFtWqkds0sIYcgV1T-sKNTJoS0MNFFfZzVl3f-hH1Cq1EOQg9sGO6dHCSyv-vnH2Xmz9URQlNA2rkwA9C6jgYwxoHrkUxGyV2IlklZitEsBFsipx3vxZ9JHx25uU8P6cgKn1o8UgorLoFGobMIlpb_8rf_MPWyVvrZLDNzxh3PlDcOlPBRUxccRmnpV5VCgDoAVjxU-Dhr5e</recordid><startdate>20120901</startdate><enddate>20120901</enddate><creator>Whang, William</creator><creator>Burg, Matthew M</creator><creator>Carney, Robert M</creator><creator>Freedland, Kenneth E</creator><creator>Bigger, J. Thomas</creator><creator>Catellier, Diane</creator><creator>Czajkowski, Susan</creator><creator>Frasure-Smith, Nancy</creator><creator>Haas, Donald C</creator><creator>Jaffe, Allan S</creator><creator>Lespérance, Francois</creator><creator>Medina, Vivian</creator><creator>Duer-Hefele, Joan</creator><creator>Osorio, Gabrielle A</creator><creator>Parsons, Faith</creator><creator>Shapiro, Peter A</creator><creator>Sheps, David S</creator><creator>Vaccarino, Viola</creator><creator>Davidson, Karina W</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20120901</creationdate><title>Design and baseline data from the vanguard of the Comparison of Depression Interventions after Acute Coronary Syndrome (CODIACS) randomized controlled trial</title><author>Whang, William ; Burg, Matthew M ; Carney, Robert M ; Freedland, Kenneth E ; Bigger, J. Thomas ; Catellier, Diane ; Czajkowski, Susan ; Frasure-Smith, Nancy ; Haas, Donald C ; Jaffe, Allan S ; Lespérance, Francois ; Medina, Vivian ; Duer-Hefele, Joan ; Osorio, Gabrielle A ; Parsons, Faith ; Shapiro, Peter A ; Sheps, David S ; Vaccarino, Viola ; Davidson, Karina W</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c506t-7190f85deaffd27ff984b0f9feef40a946cbee8cbe22e5c07b176ede2094f1f03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Acute coronary syndrome</topic><topic>Acute Coronary Syndrome - psychology</topic><topic>Aged</topic><topic>Cardiovascular</topic><topic>Clinical Protocols</topic><topic>Clinical trial</topic><topic>Depression</topic><topic>Depression - complications</topic><topic>Depression - therapy</topic><topic>Female</topic><topic>Hematology, Oncology and Palliative Medicine</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Myocardial Infarction - etiology</topic><topic>Patient Preference</topic><topic>Patient Selection</topic><topic>Psychotherapy - methods</topic><topic>Secondary Prevention</topic><topic>Serotonin Uptake Inhibitors - administration &amp; dosage</topic><topic>Serotonin Uptake Inhibitors - adverse effects</topic><topic>Serotonin Uptake Inhibitors - therapeutic use</topic><topic>Socioeconomic Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Whang, William</creatorcontrib><creatorcontrib>Burg, Matthew M</creatorcontrib><creatorcontrib>Carney, Robert M</creatorcontrib><creatorcontrib>Freedland, Kenneth E</creatorcontrib><creatorcontrib>Bigger, J. Thomas</creatorcontrib><creatorcontrib>Catellier, Diane</creatorcontrib><creatorcontrib>Czajkowski, Susan</creatorcontrib><creatorcontrib>Frasure-Smith, Nancy</creatorcontrib><creatorcontrib>Haas, Donald C</creatorcontrib><creatorcontrib>Jaffe, Allan S</creatorcontrib><creatorcontrib>Lespérance, Francois</creatorcontrib><creatorcontrib>Medina, Vivian</creatorcontrib><creatorcontrib>Duer-Hefele, Joan</creatorcontrib><creatorcontrib>Osorio, Gabrielle A</creatorcontrib><creatorcontrib>Parsons, Faith</creatorcontrib><creatorcontrib>Shapiro, Peter A</creatorcontrib><creatorcontrib>Sheps, David S</creatorcontrib><creatorcontrib>Vaccarino, Viola</creatorcontrib><creatorcontrib>Davidson, Karina W</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Contemporary clinical trials</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Whang, William</au><au>Burg, Matthew M</au><au>Carney, Robert M</au><au>Freedland, Kenneth E</au><au>Bigger, J. Thomas</au><au>Catellier, Diane</au><au>Czajkowski, Susan</au><au>Frasure-Smith, Nancy</au><au>Haas, Donald C</au><au>Jaffe, Allan S</au><au>Lespérance, Francois</au><au>Medina, Vivian</au><au>Duer-Hefele, Joan</au><au>Osorio, Gabrielle A</au><au>Parsons, Faith</au><au>Shapiro, Peter A</au><au>Sheps, David S</au><au>Vaccarino, Viola</au><au>Davidson, Karina W</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Design and baseline data from the vanguard of the Comparison of Depression Interventions after Acute Coronary Syndrome (CODIACS) randomized controlled trial</atitle><jtitle>Contemporary clinical trials</jtitle><addtitle>Contemp Clin Trials</addtitle><date>2012-09-01</date><risdate>2012</risdate><volume>33</volume><issue>5</issue><spage>1003</spage><epage>1010</epage><pages>1003-1010</pages><issn>1551-7144</issn><eissn>1559-2030</eissn><abstract>Abstract This paper describes the rationale and design of the vanguard for the Comparison of Depression Interventions after Acute Coronary Syndrome (CODIACS), a multicenter, randomized, controlled trial of a patient preference‐based, stepped care protocol for persistent depressive symptoms after acute coronary syndrome (ACS). The overall aim of the vanguard phase was to determine whether the patient-preference, stepped care protocol, which is based on the intervention used in the recent Coronary Psychosocial Evaluation Studies (COPES) trial, was feasible in patients with recent ACS who were recruited from 5 geographically diverse sites. Innovative design features of this trial include randomization to either initial patient-preference of treatment or to a referred care arm in which the primary care provider decided upon care. Additionally, delivery of psychotherapy was accomplished by telephone, or webcam, depending upon patient preference. The vanguard phase provides estimates of eligibility and screening/enrollment ratios, patient acceptance of screening, and retention. In this report, we describe the innovative features and the baseline results of the vanguard phase of CODIACS. The data from this vanguard study will be used to finalize planning for a large, phase III clinical trial designed to evaluate the effect of treatment on depressive symptoms, coronary events, and death.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>22640924</pmid><doi>10.1016/j.cct.2012.05.005</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1551-7144
ispartof Contemporary clinical trials, 2012-09, Vol.33 (5), p.1003-1010
issn 1551-7144
1559-2030
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3408827
source MEDLINE; Elsevier ScienceDirect Journals
subjects Acute coronary syndrome
Acute Coronary Syndrome - psychology
Aged
Cardiovascular
Clinical Protocols
Clinical trial
Depression
Depression - complications
Depression - therapy
Female
Hematology, Oncology and Palliative Medicine
Humans
Male
Middle Aged
Myocardial Infarction - etiology
Patient Preference
Patient Selection
Psychotherapy - methods
Secondary Prevention
Serotonin Uptake Inhibitors - administration & dosage
Serotonin Uptake Inhibitors - adverse effects
Serotonin Uptake Inhibitors - therapeutic use
Socioeconomic Factors
title Design and baseline data from the vanguard of the Comparison of Depression Interventions after Acute Coronary Syndrome (CODIACS) randomized controlled trial
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T19%3A17%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Design%20and%20baseline%20data%20from%20the%20vanguard%20of%20the%20Comparison%20of%20Depression%20Interventions%20after%20Acute%20Coronary%20Syndrome%20(CODIACS)%20randomized%20controlled%20trial&rft.jtitle=Contemporary%20clinical%20trials&rft.au=Whang,%20William&rft.date=2012-09-01&rft.volume=33&rft.issue=5&rft.spage=1003&rft.epage=1010&rft.pages=1003-1010&rft.issn=1551-7144&rft.eissn=1559-2030&rft_id=info:doi/10.1016/j.cct.2012.05.005&rft_dat=%3Celsevier_pubme%3ES1551714412001322%3C/elsevier_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/22640924&rft_els_id=S1551714412001322&rfr_iscdi=true